mRNA for livestock?

01/19/23

If cattle and livestock farmers start pumping their animals with mRNA vaccines, that will be the end of eating out meats for me unless it is 100% grass-fed beef.

COVID Vaccines ‘Opened the Floodgates’ for New Wave of mRNA Vaccines for Livestock

Several new government- and industry-funded studies are underway to develop mRNA vaccines for livestock, but “we need to be sure that no abnormal cellular or molecular changes to the animal could be induced by this type of vaccine,” one scientist told The Defender.

By 

The Defender Staff

mrna vaccines livestock big pharma feature

Miss a day, miss a lot. Subscribe to The Defender’s Top News of the DayIt’s free.

Several new government- and industry-funded studies are underway to develop mRNA vaccines for livestock, part of the massive expansion of the animal vaccine industry projected to be worth $26.12 billion by 2030.

Researchers at Iowa State University are undertaking a project funded by the U.S. Department of Agriculture to develop mRNA vaccine technology to prevent bovine respiratory syncytial virus (RSV).

Pharmaceutical company Zoetis developed an mRNA COVID-19 vaccine for animals that was administered to animals at zoos throughout the country.

And researchers in the U.S. Fish and Wildlife Service experimented with vaccinating captive-bred black-footed ferrets against COVID-19. They also experimented with social distancing and quarantine of ferrets.

Third generation vaccines,” including DNA, RNA and recombinant viral vector vaccines, are not only administered to livestock — but they also are being developed for companion animals and wild animals.

peer-reviewed study in the journal Viruses last year reported, “The successful application of mRNA vaccines against COVID-19 has further validated the platform and opened the floodgates to mRNA vaccine’s potential in infectious disease prevention, especially in the veterinary field.”

Citing the need for biosecurity, in September 2022, the New South Wales (NSW) government fast-tracked the world’s first mRNA vaccines for foot-and-mouth disease and lumpy-skin disease, in a five-year multimillion dollar deal with U.S. biotech company Tiba Biotech.

Announcing the deal, Deputy Premier and Minister for Regional NSW Paul Toole said:

“I have now written to vaccine manufacturers to take up my challenge to develop both vaccines ready for use and manufacture in NSW by August 1 next year.

“COVID-19 demonstrated to us that all possible avenues in developing vaccines must be explored and we will leave no stone unturned.”

Dugald Saunders, NSW minister for agriculture, emphasized how important it was to “protect [NSW’s] livestock sector” and said the agreement with Tiba Biotech to create mRNA vaccines, “would be a game-changer for the industry.”

But experts have raised concerns. Holistic veterinarian Dr. W. Jean Dodds, told The Defender in an email:

“Not enough is known at this time if mRNA vaccines can generate any long-term effects on reproduction or lifespan of domestic farm stock.

“As livestock become part of the human and animal food chain, we need to be sure that no abnormal cellular or molecular changes to the animal could be induced by this type of vaccine.”

Evidence Economic Freedom Improves Outcomes

The latest Economic Freedom of North America report issued by the Fraser Institute marks the first time economists have had a full four decades’ worth of data on economic freedom across the fifty United States. Those less familiar with economic research claim that economics isn’t a science because economists can’t conduct controlled experiments. Yet where economists can’t conduct controlled experiments (behavioral economists do conduct controlled experiments), they employ complicated statistical techniques to compensate for the fact that they must take data as they come. Here, the Fraser Institute has given economists a treasure-trove of data that provide insight into the effect of larger and smaller government footprints among the states’ economies.

Economic freedom is not the same as less government. In fact, in many cases, improved economic freedom requires more government. Economic freedom is rather “right government,” government that, as Thomas Jefferson put it in his first inaugural address, would “restrain (people) from injuring one another, (but) shall leave them otherwise free to regulate their own pursuits…” Societies are more economically free when their governments prevent people from harming each other, whether by violence, theft, fraud, defamation, pollution, or any of the many other ways the more powerful manage to exploit the less. But societies are also more economically free when their governments otherwise leave people and businesses alone to make decisions for themselves. Exploitation is as anathema to economic freedom as is the nanny state.

There is no perfect way to measure economic freedom, as is often the case, so  economists must settle for reasonable measures. Fraser has constructed a quasi-objective measure of economic freedom. The “quasi” part comes from the fact that Frasier’s researchers had to decide what metrics were consistent with the idea of economic freedom. The “objective” part is that government agencies put numbers to the metrics. In calculating an Economic Freedom index for each state, Fraser combines state and local government spending, government transfers and subsidies, state pension payments, tax rates and brackets, the minimum wage relative to average income, and government employment. Fraser simply averages its metrics together and puts the result on a scale from 0 (least free) to 10 (most free). Reasonable people can argue that some metrics should be weighted more than others, but Fraser tries to keep its researchers’ opinions out of the equation by taking simple averages.

As of 2020, the last year for which Fraser has performed the calculations, economic freedom among the fifty states has ranged from a low of 4.3 (New York) to a high of 7.9 (Florida). On the whole, economic freedom among the states has risen over the decades from a median of 5.2 in 1981 to almost 6.4 in 2020. That’s a remarkable improvement. Even New York State, the least free state in the union, has raised its score from 2.7 in 1981.

History of the U.S. Dollar

From thousands of different dollars, consolidated into one greenback after the civil war under Lincoln, now financing a country heavily in debt, with a break down in the rule of law, capped productivity because of the elimnation of oil in production. Are the dollar’s days numbered?

Another interesting read

Dollar bounces, PMs weaken

https://www.goldmoney.com/research/dollar-bounces-p-ms-weaken

Jan 5, 2023·Alasdair Macleod

Chart, histogram

Description automatically generated

After a strong start to the New Year, gold and silver succumbed to profit-taking as the dollar recovered slightly. In European trade this morning, gold was trading at $1837, up $14 on last Friday after hitting a high of $1864 on Wednesday. Silver was at $23.43, down 52 cents on the week, after hitting $24.50 midweek.

That precious metals would be vulnerable to profit-taking should be no surprise, given that in two months gold has rallied from $1617, and silver from under $18. These moves have been a mirror image of the dollar’s trade weighted index, which since early November fell from113 to 103.5 on 30 December, before recovering to 105.3 this morning.

While profit-taking is the order of the day for gold and silver, neither market is overbought — looking at Comex figures we see that Open Interest, a general reflection of market sentiment, remains low.

Graphical user interface, chart, line chart

Description automatically generated

While profit-taking is in traders’ minds short term, the question uppermost is the prospects for the dollar. And here we must turn to global bond market developments. After weaking on diminishing inflation concerns and increasing fears of recession, bond yields appear to be going no lower, and possibly increasing. Normally, that should provide some support for the dollar relative to gold. But there is a fly in this ointment: Japanese bond yields have risen sharply, this morning blasting through the Bank of Japan’s 0.5% ceiling for the 10-year JGB yield. This is next:

Graphical user interface, chart

Description automatically generated

The relevance is twofold. Firstly, the global carry trade through currency forwards and swaps has been shorting the yen to buy dollars to pick up yield differentials. The reversal of the yen’s spectacular fall reflects the beginning of this carry trade unwinding and probably has further to go. And secondly, with yen yields suppressed, excess capital has been invested by Japanese banks and institutions in other bond markets. 

Facing valuation losses on rising yields, Japanese institutions have already been detected selling French government bonds. They have also been reducing their US dollar interests, reflected in Treasury bonds sold $44bn between July and October, selling which is now likely to increase. Therefore, while US bond yields rise, the dollar may not rise with them as the global bond unwind accelerates.

How this plays out for precious metals remains to be seen, but it is not all bad news. Rising bond yields are unlikely to be US-led, as the sharp rise in JGB yields shows. Both the BOJ and ECB have some catching up to do, which suggests that the current dollar rally will be limited. 

Meanwhile, US M2 money supply is contracting at a record rate as our next chart shows.

Graphical user interface, application

Description automatically generated

This is bound to soften Fed rate policy, forcing a pivot on QT to QE. That will not resolve the Fed’s difficulties; instead, the developing situation is likely to highlight them.

While dollar prices for gold are still below their highs by some margin, in other currencies gold has outperformed as our last chart shows.

The views and opinions expressed in this article are those of the author(s) and do not reflect those of Goldmoney, unless expressly stated. The article is for general information purposes only and does not constitute either Goldmoney or the author(s) providing you with legal, financial, tax, investment, or accounting advice. You should not act or rely on any information contained in the article without first seeking independent professional advice. Care has been taken to ensure that the information in the article is reliable; however, Goldmoney does not represent that it is accurate, complete, up-to-date and/or to be taken as an indication of future results and it should not be relied upon as such. Goldmoney will not be held responsible for any claim, loss, damage, or inconvenience caused as a result of any information or opinion contained in this article and any action taken as a result of the opinions and information contained in this article is at your own risk.